Recurrent Priapism From Cabergoline and Bromocriptine in a Hypogonadal Man With Prolactinoma.

Autor: Menon LP; University of Arkansas for Medical Sciences, Little Rock, AR, USA., Rahman W; Piedmont Physicians Group Endocrinology, Atlanta, GA, USA.
Jazyk: angličtina
Zdroj: Journal of investigative medicine high impact case reports [J Investig Med High Impact Case Rep] 2021 Jan-Dec; Vol. 9, pp. 23247096211029750.
DOI: 10.1177/23247096211029750
Abstrakt: Dopamine agonists are generally well tolerated and represent the first-line therapy for prolactinomas. We report a case of a 20-year-old man with a macroprolactinoma who developed recurrent priapism with cabergoline and bromocriptine. Transsphenoidal pituitary adenoma resection was done with normalization of the prolactin level. Priapism is a rare side effect of dopamine agonists that warrants discontinuation of therapy. Patients should be educated about this potential side effect at the time of prescribing the medication.
Databáze: MEDLINE